Related Experiment Video
Updated: May 21, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Interventional approaches in VTE treatment (vena cava filters, catheter-guided thrombolysis, thrombosuction)
Davide Imberti1, Cinzia Maraldi, Massimo Gallerani
1Department of Internal Medicine, Piacenza Hospital, Via Taverna 49, Piacenza, Italy. d.imberti@ausl.pc.it
Insights
Venous thromboembolism (VTE) management includes anticoagulation and interventional approaches like filters and catheter-guided thrombolysis. This review details the efficacy, safety, and indications for these interventional VTE treatments.
Area of Science:
- Cardiovascular Medicine
- Interventional Radiology
- Hematology
Background:
- Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major cause of morbidity and mortality.
- Standard VTE treatment involves full-dose anticoagulation, with various agents recommended by guidelines.
- Interventional strategies are reserved for specific patient populations or complications.
Purpose of the Study:
- To review the current literature on interventional approaches for VTE treatment.
- To discuss the efficacy and safety of vena cava filters, catheter-guided thrombolysis, and thrombosuction.
- To outline appropriate clinical indications for these interventional VTE therapies.
Main Methods:
- Literature review of interventional VTE treatment modalities.
- Analysis of efficacy and safety data for vena cava filters, catheter-guided thrombolysis, and thrombosuction.
- Synthesis of evidence to guide clinical practice indications.
Main Results:
- Interventional approaches like IVC filters and catheter-directed therapies are effective in selected VTE patients.
- These interventions carry specific risks and benefits that must be weighed against anticoagulation.
- Appropriate patient selection is crucial for optimizing outcomes with interventional VTE treatments.
Conclusions:
- Interventional methods offer valuable alternatives for VTE management in specific clinical scenarios.
- Vena cava filters and catheter-guided thrombolysis have defined roles in preventing PE and treating acute VTE.
- Evidence-based guidelines are essential for the appropriate application of interventional VTE treatments.
Abstract:
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cardiovascular pathology after coronary disease and cerebrovascular diseases and is responsible for significant morbidity and mortality in the general population. Full-dose anticoagulation is the standard therapy for VTE, both the acute phase and the prolonged treatment. The latest guidelines of the American College of Chest Physicians recommend treatment with a full-dose of unfractionated heparin (UFH), low-molecular-weight-heparin (LMWH), fondaparinux, vitamin K antagonist (VKA), or systemically administered thrombolytics for most of the patients with objectively confirmed VTE. Catheter-guided thrombolysis and thrombosuction are interventional approaches that should be used only in selected populations; interruption of the inferior vena cava (IVC) with a filter can be performed to prevent life-threatening PE in patients with VTE and contraindications to anticoagulant treatment, bleeding complications during antithrombotic treatment, or VTE recurrences, despite optimal anticoagulation. This review summarizes the currently available literature regarding interventional approaches in VTE treatment (vena cava filters, catheter-guided thrombolysis, thrombosuction), discusses their efficacy and safety, and reviews the appropriate indications for their use in daily clinical practice.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care
